Bristol Myers Squibb (BMY) Return on Capital Employed Growth (5y) (2014 - 2026)

Bristol Myers Squibb (BMY) Return on Capital Employed Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 843.00
Dec 31, 2025 1,153.00
Sep 30, 2025 -235.00
Jun 30, 2025 -378.00
Mar 31, 2025 -509.00
Dec 31, 2024 -2,810.00
Sep 30, 2024 -2,498.00
Jun 30, 2024 -2,534.00
Mar 31, 2024 -2,165.00
Dec 31, 2023 -107.00
Sep 30, 2023 274.00
Jun 30, 2023 733.00
Mar 31, 2023 394.00
Dec 31, 2022 44.00
Sep 30, 2022 -149.00
Jun 30, 2022 -415.00
Mar 31, 2022 -694.00
Dec 31, 2021 -589.00
Sep 30, 2021 -1,606.00
Jun 30, 2021 -1,412.00